SCHEMBL6104909

SCHEMBL6104909

C[CH]CCOS(=O)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28393641 0.81 FNTA (0.34)
SCHEMBL21201763 0.81 FNTA (0.34)
SCHEMBL17469879 0.79 CA2 (0.36)
SCHEMBL7036524 0.77
Propene SCHEMBL21825576 0.77 CA2 (0.34)
SCHEMBL8756782 0.76 CA2 (0.35)
SCHEMBL5969210 0.75
Methane SCHEMBL6196689 0.75 CA2 (0.33)
SCHEMBL1258276 0.75
SCHEMBL562188 0.74 CA2 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060004084-A1 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors ALLERGAN, INC. 2006-01-05 US claimed
WO-2016124966-A1 INCLUSION COMPLEX BETWEEN CYCLODEXTRIN AND NON-IONIC SURFACTANTS DRUG DISCOVERY LABORATORY AS (NO) 2016-08-11 WO disclosed
US-20060004084-A1 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors ALLERGAN, INC. 2006-01-05 US disclosed